Survival impact and recurrence prediction using oncologic resectability classification in hepatocellular carcinoma following hepatic resection: a Japanese multi-center study
Authors:
- 14 July 2025
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 30 (10) , 2063-2071
Abstract
Background The oncological criteria of resectability for HCC were reported by the Japanese Expert Consensus 2023. The relationship between classification at recurrence and prognosis is unclear in cases with surgical resection in the initial treatment. Factors that predict recurrence patterns are also unknown. Methods Data were analyzed retrospectively from 937 patients who underwent hepatic resection for primary HCC at 10 facilities. Kaplan–Meier analyses of overall survival (OS) and recurrence-free survival (RFS) after hepatic resection defined according to resectability classification, resectable (R), borderline resectable (BR) 1, and BR2, were performed. In patients who underwent curative resection for R-HCC, we examined the classification and prognosis at the time of recurrence, as well as the factors associated with BR1 or BR2 recurrence. Results RFS and OS rates were significantly better in the R group than in the BR1 and BR2 groups (P < 0.01). Prognosis was worse in patients whose initial HCC was resected with R and whose recurrence was BR1 or BR2 (P < 0.01). Male sex, α-fetoprotein > 12 ng/dL, Des-γ-carboxy prothrombin > 150 mAU/mL, tumor size > 5 cm, poor differentiation, and microscopic vascular invasion were predictors of BR1 or BR2 recurrence within 2 years after curative resection for R-HCC. We developed a scoring system based on these six factors, which stratified not only prognosis but also recurrence pattern. Conclusions Our results extend this framework by demonstrating the prognostic significance at the time of recurrence and provide factors to predict high-risk recurrence.Keywords
Funding Information
- Kaken Pharmaceutical (JP-23K08133)
This publication has 18 references indexed in Scilit:
- Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter studySurgery Today, 2024
- Impact of anatomical liver resection for hepatocellular carcinoma in preventing early‐phase local recurrence after surgeryJournal of Hepato-Biliary-Pancreatic Sciences, 2024
- Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysiseClinicalMedicine, 2023
- 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsJournal of Clinical and Experimental Hepatology, 2023
- Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinomaInternational Journal of Clinical Oncology, 2022
- Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironmentsHepatology, 2021
- Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular FormationHepatology, 2020
- Liver resection for hepatocellular carcinoma in 313 Western patients: Tumor biology and underlying liver rather than tumor size drive prognosisJournal of Hepatology, 2015
- Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomyJournal of Hepatology, 2012
- Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysisSurgery Today, 2011